Literature DB >> 17978467

Piceatannol inhibits melanogenesis by its antioxidative actions.

Takako Yokozawa1, You Jung Kim.   

Abstract

In our efforts to find new skin lightening agents, piceatannol (PICE) was investigated for its antioxidative property and ability to inhibit melanogenesis. In this study, PICE's effect on inhibition of mushroom tyrosinase, and tyrosinase inhibiting activity and melanin content were assessed utilizing the B16F10 melanoma cell (B16 cell) culture system. Results indicated that PICE has a strong antityrosinase activity (IC(50)=1.53 microM). To evaluate the relative efficacy of PICE compared to other tyrosinase inhibitors, its inhibitory effect was compared and showed that PICE was significantly stronger than kojic acid (IC(50)=50.1 microM) and resveratrol (IC(50)=63.2 microM). Furthermore, PICE was shown to down-regulate melanin content. To document PICE's antioxidative property, which is known to influence melanogenic activity, we assessed reactive species (RS) generation, reduced glutathione (GSH) and oxidized glutathione (GSSG) levels in these B16 cells. The results showed that PICE suppressed RS generation and enhanced the GSH/GSSG ratio. In conclusion, our results indicated that the antimelanogenic action of PICE is likely exhibited by the combined effect of PICE's antioxidative property and its ability to suppress RS generation while increasing the GSH/GSSG ratio.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17978467     DOI: 10.1248/bpb.30.2007

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  17 in total

Review 1.  The bioactivities of resveratrol and its naturally occurring derivatives on skin.

Authors:  Ming-Hsien Lin; Chi-Feng Hung; Hsin-Ching Sung; Shih-Chun Yang; Huang-Ping Yu; Jia-You Fang
Journal:  J Food Drug Anal       Date:  2021-03-15       Impact factor: 6.157

Review 2.  Dietary activators of Sirt1.

Authors:  Joanne S Allard; Evelyn Perez; Sige Zou; Rafael de Cabo
Journal:  Mol Cell Endocrinol       Date:  2008-11-01       Impact factor: 4.102

3.  A Theoretical Study on the Antioxidant Activity of Piceatannol and Isorhapontigenin Scavenging Nitric Oxide and Nitrogen Dioxide Radicals.

Authors:  Yang Lu; AiHua Wang; Peng Shi; Hui Zhang
Journal:  PLoS One       Date:  2017-01-09       Impact factor: 3.240

4.  Piceatannol induced apoptosis through up-regulation of microRNA-181a in melanoma cells.

Authors:  Maotao Du; Zhong Zhang; Tao Gao
Journal:  Biol Res       Date:  2017-10-17       Impact factor: 5.612

5.  Activated spleen tyrosine kinase promotes malignant progression of oral squamous cell carcinoma via mTOR/S6 signaling pathway in an ERK1/2-independent manner.

Authors:  Pan Gao; Xianghe Qiao; Haibin Sun; Yi Huang; Jie Lin; Longjiang Li; Xiaoyi Wang; Chunjie Li
Journal:  Oncotarget       Date:  2017-08-03

Review 6.  An updated review of tyrosinase inhibitors.

Authors:  Te-Sheng Chang
Journal:  Int J Mol Sci       Date:  2009-05-26       Impact factor: 6.208

7.  AKT/mTOR as Novel Targets of Polyphenol Piceatannol Possibly Contributing to Inhibition of Proliferation of Cultured Prostate Cancer Cells.

Authors:  Tze-Chen Hsieh; Chia-Yi Lin; Hung-Yun Lin; Joseph M Wu
Journal:  ISRN Urol       Date:  2012-04-03

8.  Tyrosinase inhibitory activity of a glucosylated hydroxystilbene in mouse melan-a melanocytes.

Authors:  Florence Wing-Ki Cheung; Albert Wing-Nang Leung; Wing Keung Liu; Chun-Tao Che
Journal:  J Nat Prod       Date:  2014-06-16       Impact factor: 4.050

9.  Antioxidant, cell-protective, and anti-melanogenic activities of leaf extracts from wild bitter melon (Momordica charantia Linn. var. abbreviata Ser.) cultivars.

Authors:  Tsung-Hsien Tsai; Ching-Jang Huang; Wen-Huey Wu; Wen-Cheng Huang; Jong-Ho Chyuan; Po-Jung Tsai
Journal:  Bot Stud       Date:  2014-12-10       Impact factor: 2.787

10.  Inhibitory effects of different fractions of Nepeta satureioides on melanin synthesis through reducing oxidative stress.

Authors:  Seyed Ahmad Emami; Rezvan Yazdian-Robati; Mohammad Sadeghi; Javad Baharara; Elaheh Amini; Farzaneh Salek; Zahra Tayarani-Najaran
Journal:  Res Pharm Sci       Date:  2017-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.